Biotech: Pressemitteilungen - Kategorie - Seite 131

Biotech

Category / Pharmaceuticals & Biotech / Biotech


BIOSENTA Signs National Sales and Distribution Agreement With International Sales & Marketing Services Firm-CROSSMARK Canada

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/10/13 -- Biosenta Inc. (CNSX: ZRO), the makers of ZeroMold, is pleased to announce that the Company has signed a non-exclusive national sales and marketing se ...

Omni Bio Announces Support for Clinical Trial of Graft vs Host Disease

DENVER, CO: University of Michigan Cancer Center Commences Multicenter Trial ...

Theratechnologies Announces Financial Results for Second Quarter of 2013

MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 07/10/13 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the second quarter ended May 31, 2013.Second quarter f ...

BELLUS Health Amends Terms of CVRs in Connection With Its Acquisition of Thallion

LAVAL, QUEBEC: Enters into Voting Support Agreement with Jaguar Financial ...

Genetic Technologies Announces U.S. Patent Office Allows First Patent for ImmunAid

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 07/10/13 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce that ImmunAid Limited, in which GTG holds a 45% direct equity intere ...

First Ever Baby Born Through Genetic Derived Human Embryos

LIVINGSTON, NJ: Reprogenetics Researcher Dr. Dagan Wells Established Novel Genetic Screening Technique to Identify Healthiest Embryos for In Vitro Fertilization ...

Bio-Solutions Corporation Launches www.Type2Defense.com to Take Online Orders

SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 07/09/13 -- Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) - In a joint effort to accommodate the growing demand for the company's product, Bio-Solu ...

Bio-Solutions Corporation Comments on Unusual Trading Activity

SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 07/09/13 -- Bio-Solutions Corporation (OTCQB: BISU)(PINKSHEETS: BISU) is pleased to comment on the unusual trading activity in the company's common stock ...

United States Food and Drug Administration Accepts Trimel's NDA for CompleoTRT(TM)

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/09/13 -- Trimel Pharmaceuticals Corporation (TSX: TRL) today announced that the New Drug Application ("NDA") for its bioadhesive intranasal gel test ...

Lorus Therapeutics Announces Promising Clinical Results for Anticancer Drug LOR-253

TORONTO, CANADA: TORONTO, CANADA -- (Marketwired) -- 07/09/13 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus"), a biopharmaceutical company specializing in the discovery, research and development of pharmac ...

Sernova Receives Patent Allowance for Therapeutic Immune Privileged Cell Technologies

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 07/09/13 -- Sernova Corp. (TSX VENTURE: SVA) today announced the Japan Patent Office has issued a Notice of Patent Allowance to Sernova for a patent entitled, &qu ...

Dynavax Appoints Natale Ricciardi to Its Board of Directors

BERKELEY, CA: BERKELEY, CA -- (Marketwired) -- 07/08/13 -- Dynavax Technologies Corporation (NASDAQ: DVAX) announced today the appointment of Natale ("Nat") Ricciardi to its Board of Directors. Mr. Ricci ...

Type2Defense(TM) Available on the Amazon Healthy Provisions Online Store

SAN ANTONIO, TEXAS: SAN ANTONIO, TEXAS -- (Marketwired) -- 07/08/13 -- Bio-Solutions Corp. (OTCQB: BISU)(PINKSHEETS: BISU) () has done it! In this first step to the company's expansion process across the USA and c ...

Theratechnologies Inc./Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/08/13 -- Theratechnologies Inc. (TSX: TH) today announced that it has received confirmation from Health Canada that it will be meeting with a scientific advis ...

ProMetic Progresses Into a Licensing and Long-Term Supply Agreement With an Existing Multinational Client

LAVAL, QUEBEC: - ProMetic's latest commercial application of its affinity resin technology key to enabling an improved next-generation biopharmaceutical product - Agreement follows successful development and sc ...

DBV Technologies Completes Enrollment of Phase IIb VIPES Study, the First-Ever Global Trial in Desensitization to Peanut Allergy

BAGNEUX, FRANCE: BAGNEUX, FRANCE -- (Marketwired) -- 07/08/13 -- DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345) --DBV Technologies (EURONEXT PARIS: DBV) (ISIN: FR0010417345), creator of Viaskin®, a new ...

Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/05/13 -- Paladin Labs Inc. (TSX: PLB) ("Paladin") and Bioniche Life Sciences Inc. (TSX: BNC)(ASX: BNC) ("Bioniche") today announced the of ...

Biosenta Rushes ZeroMold Products to Support Flooded Calgary Community

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/04/13 -- Biosenta, Inc. (CNSX: ZRO) is pleased to announce that the Company is partnering with other leading Canadian companies to support Calgary residents a ...

Prima BioMed Activates Study Sites in Germany and Multiple European Countries for "CANVAS" Clinical Trial

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 07/03/13 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (ISIN: US74154B2034) ("Prima", the "Company") is pleased to announce that it has activ ...

Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders

EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 07/03/13 -- Ceapro Inc. (TSX VENTURE: CZO) ("Ceapro" or "the Company") announces that all Directors, Edward Taylor, Don Oborowsky, Gilles Ga ...


Seite 131 von 255:  « ..  130 131 132  133  134  135  136  137  138  139  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z